Burden of soft-tissue and bone sarcoma in routine care. Estimation of incidence, prevalence and survival for health services research.

Cancer Epidemiology

Volumn 39, Issue 3, 2015, Pages 440-446

  Trautmann, Freya ^a   Schuler, Markus ^a   Schmitt, Jochen ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Bone sarcoma; Epidemiology; Health service research; Incidence; Outcomes research; Prevalence; Routine data; Soft tissue sarcoma; Survival

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER SURVIVAL; CHILD; DATA BASE; FEMALE; GERMANY; HEALTH SERVICES RESEARCH; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MIDDLE AGED; NEWBORN; OSTEOSARCOMA; OUTCOMES RESEARCH; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; SURVIVAL RATE; SURVIVAL TIME; VERY ELDERLY; YOUNG ADULT; BONE NEOPLASMS; CAUCASIAN; FACTUAL DATABASE; INCIDENCE; MORTALITY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SARCOMA; SOFT TISSUE NEOPLASMS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GERMANY; HEALTH SERVICES RESEARCH; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 84929953804     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2015.03.002     Document Type: Article

References (24)

1. Stiller C.A., Trama A., Serraino D., Rossi S., Navarro C., Chirlaque M.D., et al. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer 2013, 49(3):684-695.
2. Skubitz K.M., D'Adamo D.R., Sarcoma Mayo Clin Proc 2007, 82(11):1409-1432.
3. Toro J.R., Travis L.B., Wu H.J., Zhu K., Fletcher C.D., Devesa S.S. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases. Int J Cancer 2006, 119(12):2922-2930.
4. Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E., et al. Cancer statistics, 2004. CA Cancer J Clin 2004, 54(1):8-29.
5. Ferlay J., Steliarova-Foucher E., Lortet-Tieulent J., Rosso S., Coebergh J.W., Comber H., et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013, 49(6):1374-1403.
6. Kaatsch P., Spix C., Hentschel S., Katalinic A., Luttmann S., Stegmaier C. Krebs in Deutschland 2009/2010 2013, Robert-Koch-Institut & Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V.
7. Ducimetiere F., Lurkin A., Ranchere-Vince D., Decouvelaere A.V., Peoc'h M., Istier L., et al. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PLoS ONE 2011, 6(8):e20294.
8. Tillack A., Werner C., Buchali A., Klug S. Flächendeckende bevölkerungsbezogene klinische Krebsregister. Onkologie 2013, 19:1065-1073.
9. Hoffmann F., Andersohn F., Giersiepen K., Scharnetzky E., Garbe E. Validierung von Sekundärdaten, Grenzen und Möglichkeiten. Bundesgesundheitsbl 2008, 51:1118-1126.
10. Schubert I., Ihle P., Koster I. Internal confirmation of diagnoses in routine statutory health insurance data: concept with examples and case definitions. Gesundheitswesen 2010, 72(6):316-322.
11. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013, 310(20):2191-2194.
12. Working Group for the Survey and Utilization of Secondary Data (AGENS) Good practice in secondary data analysis: revision after fundamental reworking. Version 2 2012.
13. Deutsches Institut für Medizinische Dokumentation und Information (DIMDI). ICD-10-WHO. [accessed 11.02.15]. http://www.dimdi.de/static/de/klassi/icd-10-who/.
14. Sozialgesetzbuch (SGB V) Gesetzliche Krankenversicherung. §295 2014, http://www.sozialgesetzbuch-sgb.de/sgbv/295.html [accessed 11.02.15].
15. National Association of Statutory Health Insurance Physicians (Kassenärztliche Bundesvereinigung) IT in der Arztpraxis - Anforderungskatalog zur Anwendung der ICD-10-GM 2014, 2.22.
16. Eurostat Revision of the European Standard Population. Report of Eurostat's task force 2013, Eurostat European Commission.
17. Anker M., Bartoszak B., Draheim S. Krebs in Sachsen. Inzidenz und Mortalität 2008-2009 2012, Gemeinsames Krebsregister der Länder Berlin, Brandenburg, Mecklenburg-Vorpommern, Sachsen-Anhalt und der Freistaaten Sachsen und Thüringen.
18. Levi F., La V.C., Randimbison L., Te V.C. Descriptive epidemiology of soft tissue sarcomas in Vaud, Switzerland. Eur J Cancer 1999, 35(12):1711-1716.
19. Mastrangelo G., Coindre J.M., Ducimetiere F., Dei Tos A.P., Fadda E., Blay J.Y., et al. Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions. Cancer 2012, 118(21):5339-5348.
20. Wibmer C., Leithner A., Zielonke N., Sperl M., Windhager R. Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review. Ann Oncol 2010, 21(5):1106-1111.
21. Schmitt J., Romanos M., Schmitt N.M., Meurer M., Kirch W. Atopic eczema and attention-deficit/hyperactivity disorder in a population-based sample of children and adolescents. JAMA 2009, 301(7):724-726.
22. Romanos M., Gerlach M., Warnke A., Schmitt J. Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J Epidemiol Community Health 2010, 64(3):269-273.
23. Abbas S., Ihle P., Köster I., Schubert I. Estimation of disease incidence in claims data dependent on the lenght of follow-up: a methodological approach. Health Res Educ Trust 2012, 47(2):746-755.
24. Federal Statistical Offices of Germany Database of the census 2011 2011.